Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension in adults: immediate and two-year follow-up results

Cao-Jin ZHANG; Yi-Gao HUANG; Xin-Sheng HUANG; Tao HUANG; Wen-Hui HUANG; Chun-Li XIA; Yu-Jing MO.
Chinese Medical Journal ; (24): 3844-3850, 2012.
Artículo en Inglés | WPRIM | ID: wpr-256630

Documentos relacionados

  1. Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension.
  2. Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
  3. Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
  4. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
  5. Anesthetic Management of Severe Pulmonary Hypertension in Pregnancy.
  6. The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension.
  7. The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
  8. Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
  9. Right atrial function is associated with right venticular diastolic stiffness: RA-RV interaction in pulmonary arterial hypertension.
  10. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.